LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 42

Search options

  1. Article ; Online: Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine.

    Sahraei, Zahra / Shabani, Minoosh / Shokouhi, Shervin / Saffaei, Ali

    International journal of antimicrobial agents

    2020  Volume 55, Issue 4, Page(s) 105945

    MeSH term(s) Betacoronavirus/drug effects ; COVID-19 ; Chloroquine/chemistry ; Chloroquine/therapeutic use ; Coronavirus Infections/drug therapy ; Humans ; Hydroxychloroquine/chemistry ; Hydroxychloroquine/therapeutic use ; Pandemics ; Pneumonia, Viral/drug therapy ; SARS-CoV-2
    Chemical Substances Hydroxychloroquine (4QWG6N8QKH) ; Chloroquine (886U3H6UFF)
    Keywords covid19
    Language English
    Publishing date 2020-03-17
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1093977-5
    ISSN 1872-7913 ; 0924-8579
    ISSN (online) 1872-7913
    ISSN 0924-8579
    DOI 10.1016/j.ijantimicag.2020.105945
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Jellyfish Stings Rarely Induced Infectious Cellulitis: First Aid Remedies as Double-Edged Sword.

    Shabani, Minoosh / Saffaei, Ali / Asghari, Mohammadali / Sahraei, Zahra

    Advanced journal of emergency medicine

    2019  Volume 4, Issue 2, Page(s) e33

    Language English
    Publishing date 2019-09-29
    Publishing country Iran
    Document type Case Reports
    ISSN 2588-400X
    ISSN (online) 2588-400X
    DOI 10.22114/ajem.v0i0.260
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Evaluation of vancomycin pharmacokinetics in patients with augmented renal clearances: A randomized clinical trial.

    Sahraei, Zahra / Saffaei, Ali / Alavi Darazam, Ilad / Salamzadeh, Jamshid / Shabani, Minoosh / Shokouhi, Shervin / Sarvmeili, Najmeh / Hajiesmaeili, Mohammadreza / Zangi, Masood

    Frontiers in pharmacology

    2022  Volume 13, Page(s) 1041152

    Abstract: Purpose: ...

    Abstract Purpose:
    Language English
    Publishing date 2022-11-11
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2587355-6
    ISSN 1663-9812
    ISSN 1663-9812
    DOI 10.3389/fphar.2022.1041152
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Emphysematous Pyelonephritis and Hiccups, a Case Report.

    Kazempour, Muhanna / Oroei, Mahbobeh / Shabani, Minoosh / Faghihi, Taraneh

    Iranian journal of kidney diseases

    2020  Volume 14, Issue 3, Page(s) 235–238

    Abstract: The initial manifestation of emphysematous pyelonephritis (EPN) with hiccups is extremely rare. We report a 47-year-old diabetic man with complaint of persistent hiccups as the first manifestation. Class 3B EPN was confirmed based on findings of Contrast- ...

    Abstract The initial manifestation of emphysematous pyelonephritis (EPN) with hiccups is extremely rare. We report a 47-year-old diabetic man with complaint of persistent hiccups as the first manifestation. Class 3B EPN was confirmed based on findings of Contrast-enhanced abdominal multi-slice CT scan. There were no neurologic deficits, Medications that lead to hiccups and gastrointestinal dysfunction. Our patient was treated with antimicrobial therapy and double J stenting. His hiccups completely resolved in one week and had no relapse.
    MeSH term(s) Anti-Bacterial Agents ; Diabetes Complications ; Emphysema ; Hiccup ; Humans ; Male ; Middle Aged ; Pyelonephritis
    Chemical Substances Anti-Bacterial Agents
    Language English
    Publishing date 2020-04-29
    Publishing country Iran
    Document type Case Reports ; Journal Article
    ZDB-ID 2388271-2
    ISSN 1735-8604 ; 1735-8582
    ISSN (online) 1735-8604
    ISSN 1735-8582
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Tocilizumab administration in patients with SARS-CoV-2 infection: Subcutaneous injection vs intravenous infusion.

    Shabani, Minoosh / Shokouhi, Shervin / Moradi, Omid / Saffaei, Ali / Sahraei, Zahra

    Journal of medical virology

    2020  Volume 93, Issue 1, Page(s) 69–70

    MeSH term(s) Antibodies, Monoclonal ; Antibodies, Monoclonal, Humanized ; COVID-19/drug therapy ; Healthy Volunteers ; Humans ; Infusions, Intravenous ; Injections, Subcutaneous ; SARS-CoV-2
    Chemical Substances Antibodies, Monoclonal ; Antibodies, Monoclonal, Humanized ; tocilizumab (I031V2H011)
    Keywords covid19
    Language English
    Publishing date 2020-06-19
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 752392-0
    ISSN 1096-9071 ; 0146-6615
    ISSN (online) 1096-9071
    ISSN 0146-6615
    DOI 10.1002/jmv.26124
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Aminoquinolines against coronavirus disease 2019 (COVID-19)

    Sahraei, Zahra / Shabani, Minoosh / Shokouhi, Shervin / Saffaei, Ali

    International Journal of Antimicrobial Agents

    chloroquine or hydroxychloroquine

    2020  Volume 55, Issue 4, Page(s) 105945

    Keywords Microbiology (medical) ; Pharmacology (medical) ; Infectious Diseases ; General Medicine ; covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    ZDB-ID 1093977-5
    ISSN 1872-7913 ; 0924-8579
    ISSN (online) 1872-7913
    ISSN 0924-8579
    DOI 10.1016/j.ijantimicag.2020.105945
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article ; Online: Cutaneous necrotic lesion: A wonderful delay adverse effect of interferon beta-1b injection for multiple sclerosis treatment.

    Mozafari, Nikoo / Saffaei, Ali / Alizadeh, Mohammad / Shabani, Minoosh

    Journal of cosmetic dermatology

    2019  Volume 19, Issue 4, Page(s) 951–953

    Abstract: Multiple sclerosis (MS) is a chronic and inflammatory autoimmune disease. These patients may manifest severe inflammatory cutaneous reactions after using interferon beta-1b. This article describes a 55-year-old man with severe injection site reactions ... ...

    Abstract Multiple sclerosis (MS) is a chronic and inflammatory autoimmune disease. These patients may manifest severe inflammatory cutaneous reactions after using interferon beta-1b. This article describes a 55-year-old man with severe injection site reactions after 10 years administration of interferon beta-1b. The biopsy specimens revealed skin and subcutaneous tissue necrosis. Histologic evaluation revealed nonspecific inflammatory reactions with no evidence of vasculitis or granulomatous reactions. Based on clinical and pathological findings, the diagnosis of skin and soft tissue necrosis due to interferon injection was given. The injection of interferon beta-1b in the affected areas was stopped, and the patient's clinical condition improved by wound care. This report is aimed to increase awareness about severe adverse skin reactions, which may infrequently occur with subcutaneous interferon beta-1b injection after several years. Early diagnosis of this reaction can help to prevent associated complications.
    MeSH term(s) Drug Eruptions/diagnosis ; Drug Eruptions/etiology ; Drug Eruptions/pathology ; Humans ; Injection Site Reaction/diagnosis ; Injection Site Reaction/etiology ; Injection Site Reaction/pathology ; Injections, Subcutaneous/adverse effects ; Interferon beta-1b/administration & dosage ; Interferon beta-1b/adverse effects ; Male ; Middle Aged ; Multiple Sclerosis/drug therapy ; Necrosis/chemically induced ; Necrosis/diagnosis ; Necrosis/pathology ; Severity of Illness Index ; Skin/drug effects ; Skin/pathology
    Chemical Substances Interferon beta-1b (145155-23-3)
    Language English
    Publishing date 2019-08-22
    Publishing country England
    Document type Case Reports ; Journal Article
    ZDB-ID 2280551-5
    ISSN 1473-2165 ; 1473-2130
    ISSN (online) 1473-2165
    ISSN 1473-2130
    DOI 10.1111/jocd.13104
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Jellyfish Stings Rarely Induced Infectious Cellulitis

    Minoosh Shabani / Ali Saffaei / Mohammadali Asghari / Zahra Sahraei

    Advanced Journal of Emergency Medicine (2019)

    First Aid Remedies as Double-Edged Sword

    2019  

    Abstract: A 27-year-old woman was presented with a burning like lesion. The skin lesion was developed after a jellyfish stings (Rhizostomae) while she was swimming in Pattaya Sea in Thailand, five days prior to her presentation. Instantly after jellyfish stings, ... ...

    Abstract A 27-year-old woman was presented with a burning like lesion. The skin lesion was developed after a jellyfish stings (Rhizostomae) while she was swimming in Pattaya Sea in Thailand, five days prior to her presentation. Instantly after jellyfish stings, she was taken into the ship for rescue operations. The ship personnel applied lemon juice and baking soda to the injured area believing that this remedy is efficient in this situation. The next day, she referred to a local hospital at Pattaya because she was suffering from a horrible pain in her arm and then she was discharged on oral Dicloxacillin and topical Hydrocortisone. The edema was extended the next days which intensified her pain. At this time, she was transferred to Loghman Hakim Hospital, Tehran, Iran. At admission, erythematous edematous patch with centrally grouped vesicles on the left arm was observed (Figure 1). The patient had a high-grade fever (38.1 °C) and was agitated due to her intolerable pain. Other vital signs were normal. In the sonography imaging, soft tissue edema was seen without any collection. According to the clinical and imaging findings, the diagnosis of soft tissue cellulitis due to jellyfish stings was made. The patient admitted to infections ward and intravenous antibiotics including Cefazolin at dose of 2000 mg every eight hours and Vancomycin at dose of 1000 mg every 12 hours initiated. After five days of hospitalization, the patient was recovered from left arm edema. Also, her pain decreased gradually and no obvious erythema was seen. The patient was finally discharged with a satisfactory clinical response
    Keywords Medicine ; R
    Language English
    Publishing date 2019-09-01T00:00:00Z
    Publisher Tehran University of Medical Sciences
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article: Tocilizumab administration in patients with SARS-CoV-2 infection: Subcutaneous injection vs intravenous infusion

    Shabani, Minoosh / Shokouhi, Shervin / Moradi, Omid / Saffaei, Ali / Sahraei, Zahra

    J. med. virol

    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #505892
    Database COVID19

    Kategorien

  10. Article ; Online: Daclatasvir/Sofosbuvir versus Ledipasvir/Sofosbuvir in Patients with Hepatitis C Virus Infection Genotypes 1 and 3

    Narjes Shokatpour / Shahnaz Sali / Ali Khahanipour / Sara Abolghasemi / Minoosh Shabani

    Novelty in Biomedicine, Vol 8, Iss 4, Pp 171-

    2020  Volume 181

    Abstract: Background: The new direct-acting antiviral agents (DAAs) with high efficacy, low resistance, and low rate of adverse events (AEs) have shown promising outcomes for hepatitis C virus (HCV) treatment. This study assessed the efficacy and safety of ... ...

    Abstract Background: The new direct-acting antiviral agents (DAAs) with high efficacy, low resistance, and low rate of adverse events (AEs) have shown promising outcomes for hepatitis C virus (HCV) treatment. This study assessed the efficacy and safety of Daclatasvir/Sofosbuvir (DCV/SOF) compared to Ledipasvir/Sofosbuvir (LDV/SOF) in patients with HCV infection in the real-world setting in Iran. Materials and Methods: A total of 42 patients with HCV infection were treated with either LDV/SOF (genotype 1) or DCV/SOF (genotypes 1, 3 or unknown) with or without ribavirin (RBV). Assessment of risk factors, laboratory tests, sustained virologic response at post-treatment week 12 (SVR12), and AEs were performed. Results: The highest risk factor for HCV transmission was major surgery (50.0%), followed by tattooing (40.5%), phlebotomy (40.5%), and dental surgery (40.5%). No statistically significant relationships between genotypes and risk factors were observed. In both treatment groups (LDV/SOF and DCV/SOF), all of the patients (100%) with or without cirrhosis and treatment-experience achieved SVR12. One patient with a history of failed LDV/SOF therapy achieved SVR12 following retreatment with DCV/SOF. Both treatment regimens were well-tolerated. No serious AEs or discontinuation due to AEs was observed. The most common AE across both treatment groups were fatigue (42.9%), followed by anxiety (28.6%). Numerically, more adverse events were found with the LDV/SOF regimen than with the DCV/SOF regimen. Conclusion: Our study showed an excellent safety and efficacy of DCV/SOF and LDV/SOF in Iranian patients infected with HCV. The incidence of AEs among patients treated with LDV/SOF was higher than those receiving SOF/DCV.
    Keywords hepatitis c ; real-world data ; direct-acting antiviral agents ; risk factors ; Medicine (General) ; R5-920
    Subject code 610
    Language English
    Publishing date 2020-06-01T00:00:00Z
    Publisher Shahid Beheshti University of Medical Sciences
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top